spacer
home > news > detailed info
INDUSTRY NEWS AND PRESS RELEASES

CIDP Showcases Full Suite of Services at in-cosmetics North America 2017

CIDP (Centre International de Développement Pharmaceutique)

Independent CRO Adds Ex Vivo Model to its Claims Substantiation Protocols

Mauritius, 29 September 2017 – CIDP, Centre International de Développement Pharmaceutique, a Mauritius-based private and independent Contract Research Organisation (CRO), will bring its full suite of services – comprising research activities, in vitro and ex vivo testing, analytical chemistry, formulation, and clinical research – to in-cosmetics North America 2017. CIDP will also present its innovative anti-pollution and blue light study protocols, and reveal a new ex vivo model at the show.

Earlier this year, CIDP unveiled its innovative study protocol for substantiating anti-pollution claims on cosmetic products. Since then, the company has developed an ex vivo model as an addition to its anti-pollution and blue light claim substantiation protocols. This new model allows experiments to be conducted in conditions close to the in vivo model.

The ex vivo model of viable full-thickness skin explants reproduces the same mechanisms that are activated in the different cell layers of the human skin, enabling CIDP researchers to closely monitor the effects of pollution on the skin.

On 11 October at 11:10am, Mrs Véronique NEWTON, Preclinical Laboratory Manager at CIDP, will present the company’s standard protocols for objective substantiation of anti-pollution claims. She will also share more about CIDP’s successful creation of an ex vivo model that mimics in vivo conditions.

“CIDP aims to be the ideal partner to cosmetic manufacturers for their research needs,” commented Mr Jean-Louis ROULE, CEO of CIDP. “Our anti-pollution and blue light protocols had been well-received in Europe, and we’re excited to introduce our ex vivo protocol at in-cosmetics North America this year. The United States is an important market for CIDP, and we’re looking to build on our success in Europe, and strengthen our international strategy by establishing our presence here.”

Visitors can learn more about CIDP’s study protocols and full suite of services at Stand B1.

For more information, please visit www.cidp-cro.com.



phone +230 401 2600
email info@cidp-cro.com
web www.cidp-cro.com/
email BioPark Mauritius, Socota Phoenicia, Sayed Hossen Road, Phoenix 73408, Mauritius
 
Print this page
Send to a friend
   
spacer
News and Press Releases

Media Advisory AD Communications appointed PR Agency for PPMA

Please be advised that the PPMA Group of Associations has appointed AD Communications as PR agency with responsibility for its corporate and PPMA Show accounts.
More info >>


White Papers

New Temperature Profiles from a Global Study

Laminar Medica

Recently there has been an influx of temperature mapping studies to collect sufficient ambient data to develop temperature profiles.  Solid temperature profiles on specific shipping routes are required to ensure streamlined packaging and robust lane qualification. The most reliable method to develop temperature profiles is to capture the actual reading from shipments, as well as using the historical and meteorological data to increase the confidence level.
More info >>

Industry Events

Clinical Innovation Partnerships 2018

3-4 July 2018, Radisson Blu Hotel, Zurich Airport

Clinical Innovation Partnerships is the only event for senior clinical operations and procurement professionals driving innovation in their clinical trials. It is where the pharma, CRO and vendor clinical trials ecosystem meet to drive innovation in digitalisation, tech and partnering to improve patient experience and reduce trial cost and time.
More info >>

 
©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement